|
1
|
Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms.
|
J Urol
|
2003
|
1.58
|
|
2
|
Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.
|
BJU Int
|
2005
|
0.97
|
|
3
|
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
|
BJU Int
|
2008
|
0.94
|
|
4
|
Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.
|
Urology
|
2005
|
0.87
|
|
5
|
Completeness of bladder cancer staging in the Danish Cancer Registry, 2004-2009.
|
Clin Epidemiol
|
2012
|
0.87
|
|
6
|
Completeness of prostate cancer staging in the Danish Cancer Registry, 2004-2009.
|
Clin Epidemiol
|
2012
|
0.87
|
|
7
|
Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice.
|
BJU Int
|
2006
|
0.80
|
|
8
|
Are cystoscopy and urinary cytology sufficient to identify candidates for subsequent biopsy after bacillus Calmette-Guérin treatment in patients with bladder carcinoma in situ?
|
Scand J Urol
|
2015
|
0.75
|